Literature DB >> 363951

The use of the preparation of F(ab')2 antibody from soluble immune complexes to determine the complexed antigens.

C Dambuyant, J Burton-Kee, J F Mowbray.   

Abstract

An autoradiographic technique for the characterization of antibody specificity in soluble antigen--antibody complexes has been developed. The circulating antigen--antibody complexes are precipitated by polyethylene glycol (PEG). The antibodies are liberated as F(ab')2 from the complexes by pepsin digestion. The antibody specificity against the putative antigen was revealed by radioimmunoelectrophoresis using [125I]-F(ab')2 reagents. The method was developed by using an experimental model of C3/anti-C3 complexes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 363951     DOI: 10.1016/0022-1759(78)90083-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Electrophoretic transfer blotting analysis of immune complexes in rheumatoid arthritis.

Authors:  R D Inman; N C Hamilton; P B Redecha; D M Hochhauser
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

2.  Demonstration of two disease specific antigens in circulating immune complexes.

Authors:  C Dambuyant; J Burton-Kee; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

3.  Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.

Authors:  C Bruneau; H Bonin
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  Nature of circulating immune complexes in infective endocarditis.

Authors:  J Burton-Kee; P Morgan-Capner; J F Mowbray
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

5.  Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.

Authors:  M D Kazatchkine; Y Sultan; E J Burton-Kee; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.